SARAH WILSON: Open Payments
NPI 1558998625 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,653 in 216 payments from 30 companies in 2025. Trend: 2023 $1,675 · 2024 $1,631 · 2025 $3,653
Food & beverage: $3,653
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 46 | $468 |
| UCB, Inc. | 34 | $378 |
| Janssen Biotech, Inc. | 11 | $284 |
| ARGENX US, INC. | 9 | $275 |
| Neurocrine BioSciences, Inc. | 8 | $212 |
| ACADIA Pharmaceuticals Inc | 11 | $191 |
| Genentech USA, Inc. | 12 | $176 |
| Merz Pharmaceuticals, LLC | 8 | $175 |
| Otsuka America Pharmaceutical, Inc. | 6 | $151 |
| Neurelis, Inc. | 8 | $141 |
Products named: NURTEC ODT, INGREZZA, NUPLAZID, Xeomin, REXULTI, Briviact, VYVGART, VALTOCO.
Industry payments across AL — which companies pay providers there.
